Evropska unija - slovenščina - EMA (European Medicines Agency)

ultragenyx germany gmbh - evinacumab - hiperholesterolemija - sredstva za spreminjanje lipidov - evkeeza is indicated as an adjunct to diet and other low-density lipoprotein-cholesterol (ldl-c) lowering therapies for the treatment of adult and adolescent patients aged 12 years and older with homozygous familial hypercholesterolaemia (hofh).

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

inhibitor c1-esteraze - prašek in vehikel za raztopino za injiciranje - inhibitor c1-esteraze 2000 i.e. / 1 viala - zaviralec c1, pridobljen iz plazme

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

inhibitor c1-esteraze - prašek in vehikel za raztopino za injiciranje - inhibitor c1-esteraze 3000 i.e. / 1 viala - zaviralec c1, pridobljen iz plazme

Evropska unija - slovenščina - EMA (European Medicines Agency)

bial portela & companhia s.a. - opikapon - parkinsonova bolezen - anti-parkinsonska zdravila - ontilyv is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.

Evropska unija - slovenščina - EMA (European Medicines Agency)

alnylam netherlands b.v. - vutrisiran sodium - amyloid neuropathies, familial - druga zdravila na živčnem sistemu - treatment of hereditary transthyretin-mediated amyloidosis (hattr amyloidosis) in adult patients with stage 1 or stage 2 polyneuropathy.

Evropska unija - slovenščina - EMA (European Medicines Agency)

eli lilly nederland b.v. - mirikizumab - kolitis, ulcerativni - imunosupresivi - omvoh is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic treatment.